EURETINA CONGRESS DAILY
Latest News from Euretina 2026
Nearly 10,000 Global Specialists Gather as EURETINA 2026 Opens in Vienna
Euretina President Professor Nicole Eter officially opened the 26th Congress on Thursday afternoon, welcoming registrants to Vienna.
Redefining Diabetic Retinopathy: EURETINA Experts Highlight AI Screening, Novel Drug Delivery, and Early Neurodegeneration
Speakers in Thursday afternoon’s Euretina session on diabetic retinopathy (DR) and diabetic macular oedema (DMO) covered a range of topics that included screening and early detection of DR, novel methods for treatment delivery and applications for imaging techniques.
Meet the Winners: Best Free Papers, ePosters and Videos
The winners of this year’s Best Free Paper, Best ePoster and Best Video awards were announced during the Opening Ceremony. Here is where and when to see each winning presentation.
Eye Openers: Master Surgeons Share Hard-Won Lessons and Surgical Rescue Strategies
The Euretina Session track at the 2026 Congress began on Thursday morning with a programme titled “Eye Openers”. In this video-based interactive session, six experienced retina specialists presented lessons learned from challenging vitreoretinal surgery cases. At junctures when complications occurred throughout the cases, input on next steps was sought from a faculty panel and audience members equipped with electronic response keypads.
Euretina Lecture Preview: The Dark Side of the Moon: New Horizons in Dry AMD
Euretina lecturer delineates research challenges, progress, and strategies for addressing knowledge gaps and treatment needs for dry age-related macular degeneration.
Elevating Science: Explore the Revamped Free Paper Forums and Poster Hub
At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?
EURETINA Innovation Spotlight (EIS) Kicks Off Vienna Congress in Style
The 4th annual EURETINA Innovation Spotlight (EIS) held on Wednesday afternoon proved again that the programme is a rich educational opportunity for all attendees and a valuable forum for networking and collaboration. Therefore, it is easy to understand why the EIS has become a not-to-be-missed event for physicians, researchers, and industry representatives attending the EURETINA Congress.
Beyond Incremental Gains: EIS 2026 Investor Panel Highlights Differentiated Science and Next-Gen Therapies
The Investor Panel at EIS 2026 compromised an international group of four participants who answered questions posed by moderators Kourous Rezaei, MD and Martin Zinkernagel, MD, PhD.
AI in Medicines Development: EMA Shares Progress, Risks, and Regulatory Roadmap
At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?
Ninth Annual EURETINA Clinical Trends Survey Underway: Your Participation is Essential!
Survey participants will be entered into a raffle to receive a free registration for the EURETINA 2027 Congress and will receive a summary report before it is published.
Kreissig Lecture Preview: Optimising Tamponades to Repair Rhegmatogenous Retinal Detachment
Kreissig Award lecturer reviews the evidence base and scientific rationale for use of vitreous cavity tamponades in the repair of rhegmatogenous retinal detachment and looks ahead to the possibility of a tamponade-free future.
Gisbert Lecture Preview: Understanding Diabetic Tractional Retinal Detachment and Generating Evidence to Improve Patient’s Care
Gisbert Richard Lecturer will review existing evidence regarding the development and management of diabetic tractional retinal detachment and research needed to fill knowledge gaps that will enable better patient care.
The European Board of Ophthalmology and EURETINA Celebrate 4 years of FEBOS-R Subspecialty Certification by Awarding FEBOS-R (Hons) Diplomas
8 Exam Leaders join Prof Nicole Eter and Prof Jens Folke Kiilgaard as FEBOS-R (Hon) Awardees
Looking ahead to the future of EURETINA and the 2026 Congress with Prof. Nicole Eter, President of EURETINA
Prof. Nicole Eter, President of EURETINA, outlines her priorities and plans for the Society and previews some of the changes and highlights of the 2026 Congress programme.
Join us TODAY at the EURETINA IME Platform on Digital Visualisation and Vitreoretinal Surgery!
Discover how the latest digital visualisation technologies are transforming vitreoretinal surgery, from innovation into everyday clinical practice.
Bridging Innovation and Approval: EMA Regulators Outline the Future of Ophthalmic Development
Taking place Thursday, 1 October, from 15:00 to 16:00 CEST in Room 4, this 60-minute symposium, chaired by Hemme Hijma and Elisabeth Wischnitzki, covers basic principles and current clinical and methodological topics in EU medicines regulation as applied directly to ophthalmology.
World Retina @ Euretina: Launching a Truly Global Exchange in Vienna
At EURETINA 2026 in Vienna, the international retina community marks a landmark evolution in global scientific exchange with the official launch of the World Retina @ Euretina initiative. Grounded at the World Retina Plaza stage, this new four-day format brings together 35 international organizations and national societies, representing a global community spanning more than 140 countries.
Your Early-Career Guide to Hidden Gems, Global Perspectives, and Networking at EURETINA 2026
For young ophthalmologists and early-career retina fellows arriving in Vienna, the EURETINA Congress is more than just a place to watch keynotes from the back row—it is your launchpad for career growth, clinical learning, and building a global professional network. Beyond the large symposia, here are the high-yield, interactive features designed to accelerate your development.
Beyond the Congress: An Insider’s Sightseeing Guide to Vienna
EURETINA 2026 has arrived in Vienna — and while you’re here for the retina research, you’re also in the capital of imperial elegance, historic coffeehouses, and effortless charm Whether you’ve carved out a full free day or just an hour between sessions, there are endless ways to soak up the Viennese atmosphere without falling into the tourist traps
Top Tips for Every Attendee
Heading into EURETINA 2026 in Vienna (1–4 October 2026), smooth congress navigation requires a quick mix of logistical planning and venue transit know-how. Here is your operational guide to maximizing your time at VIECON and getting the most out of the scientific programme:
Talking EURETINA: Your Year-Round Gateway to Retinal Science, Expert Interviews, and Career Growth
The world of retinal science moves at an unprecedented pace. Groundbreaking clinical trial data, novel surgical instrumentation, and evolving diagnostic paradigms emerge constantly—far beyond the four days of our annual autumn congress. To bridge the gap between major scientific meetings and keep the global ophthalmic community continuously informed, the European Society of Retina Specialists presents Talking EURETINA: the society’s official flagship podcast series.